+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Urinary Tract Infection Market - Global Forecast 2026-2032- Product Image
Urinary Tract Infection Market - Global Forecast 2026-2032- Product Image
New

Urinary Tract Infection Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 188 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4986010
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The urinary tract infection market is experiencing rapid evolution, driven by new models of care, advancing clinical technologies, and shifts in patient demographics. For business leaders and senior executives, staying ahead of these changes is essential for operational resilience, effective strategic planning, and capitalizing on new healthcare opportunities.

Market Snapshot: Urinary Tract Infection Market Size and Growth

The global urinary tract infection market expanded from USD 10.24 billion in 2025 to USD 10.96 billion in 2026 and is projected to reach USD 16.62 billion by 2032, reflecting a compound annual growth rate (CAGR) of 7.15%. This market trajectory is being shaped by increased disease awareness, improved access to both conventional and innovative therapies, and evolving clinical practices across major global regions. Heightened adoption of targeted diagnostics complements the expansion, ensuring that treatment delivery meets rising quality and efficiency expectations in mature and emerging markets alike.

Scope & Segmentation: Comprehensive View of Segment Dynamics

  • Therapy Classes: Antibiotic agents such as fosfomycin, nitrofurantoin, and trimethoprim/sulfamethoxazole remain the mainstay for managing infection, while non-antibiotic alternative options—including D Mannose, phenazopyridine, and probiotics—are increasingly recognized for prevention and symptom relief.
  • Patient Demographics: This market encompasses adults requiring routine care, geriatric populations with higher complexity and recurrence, pediatric groups with specialized dosing and family involvement, as well as gender-based subgroups to address unique prevalence and management needs.
  • Care Channels: Care settings span from outpatient clinics and ambulatory centers providing first-line intervention, to home-based and telemedicine-enabled services supporting remote monitoring and prevention, and hospital facilities for advanced diagnostics or complex cases.
  • Regional Markets: The Americas continue to emphasize advanced diagnostics and antibiotic stewardship. Europe, Middle East, and Africa reveal diverse procurement and regulatory frameworks, demanding adaptable commercial strategies. Asia-Pacific encompasses various levels of healthcare maturity and infrastructure, making regional customization essential for effective market entry and sustained operation.
  • Technology Use: Rapid diagnostic platforms, point-of-care solutions, and telemedicine tools are being integrated to speed up detection, bolster treatment adherence, and optimize selection of therapy. Ongoing investments in these technologies are improving workflows, clinical outcomes, and market reach.

Key Takeaways: Strategic Insights for Urinary Tract Infection Market Stakeholders

  • Innovation in clinical pathways is increasingly central, emphasizing not only therapeutic efficiency but also regulatory stewardship and resistance mitigation for market longevity and risk management.
  • Telehealth and home care advancements enhance patient involvement, providing convenience and supporting ongoing care for both acute and recurrent cases in diverse settings.
  • Manufacturers must align product features with evidence of comparative clinical value, as payers and regulatory agencies require robust demonstration of stewardship and effectiveness in both original and generic launches.
  • Segmentation expertise—including detailed insight into patient profiles, care environments, and regional characteristics—enables tailored product positioning and increases the effectiveness of evidence generation and support initiatives.
  • Integration of diagnostics with therapeutics, sometimes bundled with digital health capabilities, is essential for ensuring reliable, efficient care and responding to changing reimbursement frameworks globally.

Tariff Impact: Navigating Supply Chain Complexity

Recent shifts in global tariff structures and trade policy affect production and distribution strategies for market participants. Companies are actively adjusting procurement and commercial tactics to maintain reliable supply and competitive pricing despite increasing volatility.

  • Supply network diversification and dual-sourcing are critical to ensure access to vital pharmaceutical ingredients and related components.
  • Enhanced transparency in sourcing empowers organizations to better address volatile price fluctuations and react quickly to modifications in import duties and taxes.
  • Strategic partnerships with logistics providers and local manufacturers minimize risks linked to international disruptions, ensuring operational consistency.
  • Contracting strategies are being refined with an emphasis on consistent supply, allowing firms to enhance commercial reliability and strengthen long-term resilience.

Organizations that build adaptable supply models and agile commercial strategies are more likely to sustain market presence and service delivery through uncertainty.

Methodology & Data Sources

This analysis combines structured interviews with clinicians and health system executives, an extensive literature review, regulatory and supply chain landscape studies, and validation by independent regional experts. Methodological rigor supports actionable, trustworthy findings for informed executive decision-making.

Why This Report Matters

  • Empowers leaders to build portfolios and development strategies in alignment with evolving care models and shifting patient needs.
  • Enables preemptive action on procurement, regulatory, and supply chain challenges, supporting operational stability and growth planning.
  • Equips commercial teams with high-impact segmentation and market dynamics intelligence to sharpen go-to-market and competitive strategies.

Conclusion

Market stakeholders prioritizing innovation, clinical integration, and supply flexibility will be best positioned to thrive within the shifting urinary tract infection landscape. Access the full report for detailed, region-specific strategies tailored to supplier and commercial objectives.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Urinary Tract Infection Market, by Treatment
8.1. Antibiotics
8.1.1. Fosfomycin
8.1.2. Nitrofurantoin
8.1.3. Trimethoprim/Sulfamethoxazole
8.1.4. Penicillins
8.1.5. Cephalosporins
8.1.6. Fluoroquinolones
8.2. Non Antibiotic Therapies
8.2.1. D-mannose
8.2.2. Probiotics
8.2.3. Immunomodulatory Supplements
9. Urinary Tract Infection Market, by Diagnosis Method
9.1. Urinalysis
9.2. Urine Culture
9.3. Dipstick Tests
9.4. Molecular Diagnostics
9.5. Point-of-Care Testing
10. Urinary Tract Infection Market, by Infection Type
10.1. Uncomplicated Cystitis
10.2. Complicated Urinary Tract Infection
10.3. Pyelonephritis
10.4. Recurrent Urinary Tract Infection
10.5. Catheter-Associated Urinary Tract Infection
10.6. Asymptomatic Bacteriuria
11. Urinary Tract Infection Market, by Age Group
11.1. Adults
11.2. Geriatrics
11.3. Pediatrics
12. Urinary Tract Infection Market, by Infection Site
12.1. Lower Tract Infection
12.1.1. Cystitis
12.1.2. Urethritis
12.2. Upper Tract Infection
12.2.1. Pyelonephritis
12.2.2. Ureteritis
13. Urinary Tract Infection Market, by Route Of Administration
13.1. Oral Route
13.2. Intravenous Route
13.3. Intramuscular Route
13.4. Intravesical Route
14. Urinary Tract Infection Market, by Pathogen Type
14.1. Bacterial Pathogens
14.1.1. Escherichia Coli
14.1.2. Klebsiella Species
14.1.3. Proteus Species
14.1.4. Pseudomonas Aeruginosa
14.1.5. Enterococcus Species
14.1.6. Staphylococcus Saprophyticus
14.2. Fungal Pathogens
14.3. Viral Pathogens
14.4. Parasitic Pathogens
15. Urinary Tract Infection Market, by End User
15.1. Clinics & Outpatient Centers
15.2. Homecare Settings
15.3. Hospitals
15.4. Diagnostic Laboratories
15.5. Long-Term Care Facilities
16. Urinary Tract Infection Market, by Region
16.1. Americas
16.1.1. North America
16.1.2. Latin America
16.2. Europe, Middle East & Africa
16.2.1. Europe
16.2.2. Middle East
16.2.3. Africa
16.3. Asia-Pacific
17. Urinary Tract Infection Market, by Group
17.1. ASEAN
17.2. GCC
17.3. European Union
17.4. BRICS
17.5. G7
17.6. NATO
18. Urinary Tract Infection Market, by Country
18.1. United States
18.2. Canada
18.3. Mexico
18.4. Brazil
18.5. United Kingdom
18.6. Germany
18.7. France
18.8. Russia
18.9. Italy
18.10. Spain
18.11. China
18.12. India
18.13. Japan
18.14. Australia
18.15. South Korea
19. United States Urinary Tract Infection Market
20. China Urinary Tract Infection Market
21. Competitive Landscape
21.1. Market Concentration Analysis, 2025
21.1.1. Concentration Ratio (CR)
21.1.2. Herfindahl Hirschman Index (HHI)
21.2. Recent Developments & Impact Analysis, 2025
21.3. Product Portfolio Analysis, 2025
21.4. Benchmarking Analysis, 2025
21.5. AbbVie Inc.
21.6. Almirall, SA
21.7. Aspen Pharmacare Holdings Limited
21.8. AstraZeneca PLC
21.9. Bayer AG
21.10. Beckman Coulter, Inc.
21.11. Boehringer Ingelheim International GmbH
21.12. Bristol-Myers Squibb Company
21.13. Cipla Limited
21.14. Dr Reddys Laboratories Ltd.
21.15. Eli Lilly and Company
21.16. F Hoffmann-La Roche AG
21.17. GlaxoSmithKline PLC
21.18. Johnson & Johnson Services, Inc.
21.19. Lupin Ltd.
21.20. Merck & Co Inc.
21.21. Novartis AG
21.22. Novo Nordisk A/S
21.23. Pfizer Inc.
21.24. PhenUtest Diagnostics Ltd.
21.25. Randox Laboratories Ltd.
21.26. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
21.27. Shionogi & Co, Ltd.
21.28. Siemens Healthineers AG
21.29. Sun Pharmaceutical Industries Limited
21.30. Sysmex Corporation
21.31. Teva Pharmaceutical Industries Ltd.
21.32. URIT Medical Electronic Co., Ltd.
21.33. Viatris Inc
List of Figures
FIGURE 1. GLOBAL URINARY TRACT INFECTION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL URINARY TRACT INFECTION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL URINARY TRACT INFECTION MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY DIAGNOSIS METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY INFECTION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY INFECTION SITE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PATHOGEN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 15. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 16. CHINA URINARY TRACT INFECTION MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL URINARY TRACT INFECTION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY FOSFOMYCIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY FOSFOMYCIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY FOSFOMYCIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY NITROFURANTOIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY NITROFURANTOIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY NITROFURANTOIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TRIMETHOPRIM/SULFAMETHOXAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TRIMETHOPRIM/SULFAMETHOXAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY TRIMETHOPRIM/SULFAMETHOXAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PENICILLINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PENICILLINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CEPHALOSPORINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CEPHALOSPORINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY FLUOROQUINOLONES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY FLUOROQUINOLONES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY D-MANNOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY D-MANNOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY D-MANNOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY IMMUNOMODULATORY SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY IMMUNOMODULATORY SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY IMMUNOMODULATORY SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY URINALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY URINALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY URINALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY URINE CULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY URINE CULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY URINE CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY DIPSTICK TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY DIPSTICK TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY DIPSTICK TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY POINT-OF-CARE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY POINT-OF-CARE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY UNCOMPLICATED CYSTITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY UNCOMPLICATED CYSTITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY UNCOMPLICATED CYSTITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY COMPLICATED URINARY TRACT INFECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY COMPLICATED URINARY TRACT INFECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY COMPLICATED URINARY TRACT INFECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PYELONEPHRITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PYELONEPHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY RECURRENT URINARY TRACT INFECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY RECURRENT URINARY TRACT INFECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY RECURRENT URINARY TRACT INFECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CATHETER-ASSOCIATED URINARY TRACT INFECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CATHETER-ASSOCIATED URINARY TRACT INFECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CATHETER-ASSOCIATED URINARY TRACT INFECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ASYMPTOMATIC BACTERIURIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ASYMPTOMATIC BACTERIURIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ASYMPTOMATIC BACTERIURIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY GERIATRICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY GERIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY INFECTION SITE, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY LOWER TRACT INFECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY LOWER TRACT INFECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY LOWER TRACT INFECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY LOWER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CYSTITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CYSTITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CYSTITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY URETHRITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY URETHRITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY URETHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY UPPER TRACT INFECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY UPPER TRACT INFECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY UPPER TRACT INFECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY UPPER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PYELONEPHRITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PYELONEPHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY URETERITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY URETERITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY URETERITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ORAL ROUTE, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ORAL ROUTE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ORAL ROUTE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY INTRAVENOUS ROUTE, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY INTRAVENOUS ROUTE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY INTRAVENOUS ROUTE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY INTRAMUSCULAR ROUTE, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY INTRAMUSCULAR ROUTE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY INTRAMUSCULAR ROUTE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY INTRAVESICAL ROUTE, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY INTRAVESICAL ROUTE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY INTRAVESICAL ROUTE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY BACTERIAL PATHOGENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY BACTERIAL PATHOGENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY BACTERIAL PATHOGENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY BACTERIAL PATHOGENS, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ESCHERICHIA COLI, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ESCHERICHIA COLI, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ESCHERICHIA COLI, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY KLEBSIELLA SPECIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY KLEBSIELLA SPECIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY KLEBSIELLA SPECIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PROTEUS SPECIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PROTEUS SPECIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PROTEUS SPECIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PSEUDOMONAS AERUGINOSA, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PSEUDOMONAS AERUGINOSA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PSEUDOMONAS AERUGINOSA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ENTEROCOCCUS SPECIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ENTEROCOCCUS SPECIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY ENTEROCOCCUS SPECIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY STAPHYLOCOCCUS SAPROPHYTICUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY STAPHYLOCOCCUS SAPROPHYTICUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY STAPHYLOCOCCUS SAPROPHYTICUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY FUNGAL PATHOGENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY FUNGAL PATHOGENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY FUNGAL PATHOGENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY VIRAL PATHOGENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY VIRAL PATHOGENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY VIRAL PATHOGENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PARASITIC PATHOGENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PARASITIC PATHOGENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY PARASITIC PATHOGENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CLINICS & OUTPATIENT CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CLINICS & OUTPATIENT CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY CLINICS & OUTPATIENT CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 167. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 168. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 169. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2032 (USD MILLION)
TABLE 170. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2032 (USD MILLION)
TABLE 171. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 172. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 173. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY INFECTION SITE, 2018-2032 (USD MILLION)
TABLE 174. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY LOWER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 175. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY UPPER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 176. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 177. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 178. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY BACTERIAL PATHOGENS, 2018-2032 (USD MILLION)
TABLE 179. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. NORTH AMERICA URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. NORTH AMERICA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 182. NORTH AMERICA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 183. NORTH AMERICA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2032 (USD MILLION)
TABLE 184. NORTH AMERICA URINARY TRACT INFECTION MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2032 (USD MILLION)
TABLE 185. NORTH AMERICA URINARY TRACT INFECTION MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 186. NORTH AMERICA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 187. NORTH AMERICA URINARY TRACT INFECTION MARKET SIZE, BY INFECTION SITE, 2018-2032 (USD MILLION)
TABLE 188. NORTH AMERICA URINARY TRACT INFECTION MARKET SIZE, BY LOWER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 189. NORTH AMERICA URINARY TRACT INFECTION MARKET SIZE, BY UPPER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 190. NORTH AMERICA URINARY TRACT INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 191. NORTH AMERICA URINARY TRACT INFECTION MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 192. NORTH AMERICA URINARY TRACT INFECTION MARKET SIZE, BY BACTERIAL PATHOGENS, 2018-2032 (USD MILLION)
TABLE 193. NORTH AMERICA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. LATIN AMERICA URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. LATIN AMERICA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 196. LATIN AMERICA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 197. LATIN AMERICA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2032 (USD MILLION)
TABLE 198. LATIN AMERICA URINARY TRACT INFECTION MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2032 (USD MILLION)
TABLE 199. LATIN AMERICA URINARY TRACT INFECTION MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 200. LATIN AMERICA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 201. LATIN AMERICA URINARY TRACT INFECTION MARKET SIZE, BY INFECTION SITE, 2018-2032 (USD MILLION)
TABLE 202. LATIN AMERICA URINARY TRACT INFECTION MARKET SIZE, BY LOWER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 203. LATIN AMERICA URINARY TRACT INFECTION MARKET SIZE, BY UPPER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 204. LATIN AMERICA URINARY TRACT INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 205. LATIN AMERICA URINARY TRACT INFECTION MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 206. LATIN AMERICA URINARY TRACT INFECTION MARKET SIZE, BY BACTERIAL PATHOGENS, 2018-2032 (USD MILLION)
TABLE 207. LATIN AMERICA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2032 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2032 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY INFECTION SITE, 2018-2032 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY LOWER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY UPPER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY BACTERIAL PATHOGENS, 2018-2032 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 222. EUROPE URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. EUROPE URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 224. EUROPE URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 225. EUROPE URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2032 (USD MILLION)
TABLE 226. EUROPE URINARY TRACT INFECTION MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2032 (USD MILLION)
TABLE 227. EUROPE URINARY TRACT INFECTION MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 228. EUROPE URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 229. EUROPE URINARY TRACT INFECTION MARKET SIZE, BY INFECTION SITE, 2018-2032 (USD MILLION)
TABLE 230. EUROPE URINARY TRACT INFECTION MARKET SIZE, BY LOWER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 231. EUROPE URINARY TRACT INFECTION MARKET SIZE, BY UPPER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 232. EUROPE URINARY TRACT INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 233. EUROPE URINARY TRACT INFECTION MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 234. EUROPE URINARY TRACT INFECTION MARKET SIZE, BY BACTERIAL PATHOGENS, 2018-2032 (USD MILLION)
TABLE 235. EUROPE URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 236. MIDDLE EAST URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 237. MIDDLE EAST URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 238. MIDDLE EAST URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 239. MIDDLE EAST URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2032 (USD MILLION)
TABLE 240. MIDDLE EAST URINARY TRACT INFECTION MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2032 (USD MILLION)
TABLE 241. MIDDLE EAST URINARY TRACT INFECTION MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 242. MIDDLE EAST URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 243. MIDDLE EAST URINARY TRACT INFECTION MARKET SIZE, BY INFECTION SITE, 2018-2032 (USD MILLION)
TABLE 244. MIDDLE EAST URINARY TRACT INFECTION MARKET SIZE, BY LOWER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 245. MIDDLE EAST URINARY TRACT INFECTION MARKET SIZE, BY UPPER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 246. MIDDLE EAST URINARY TRACT INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 247. MIDDLE EAST URINARY TRACT INFECTION MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 248. MIDDLE EAST URINARY TRACT INFECTION MARKET SIZE, BY BACTERIAL PATHOGENS, 2018-2032 (USD MILLION)
TABLE 249. MIDDLE EAST URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 250. AFRICA URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 251. AFRICA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 252. AFRICA URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 253. AFRICA URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2032 (USD MILLION)
TABLE 254. AFRICA URINARY TRACT INFECTION MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2032 (USD MILLION)
TABLE 255. AFRICA URINARY TRACT INFECTION MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 256. AFRICA URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 257. AFRICA URINARY TRACT INFECTION MARKET SIZE, BY INFECTION SITE, 2018-2032 (USD MILLION)
TABLE 258. AFRICA URINARY TRACT INFECTION MARKET SIZE, BY LOWER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 259. AFRICA URINARY TRACT INFECTION MARKET SIZE, BY UPPER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 260. AFRICA URINARY TRACT INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 261. AFRICA URINARY TRACT INFECTION MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 262. AFRICA URINARY TRACT INFECTION MARKET SIZE, BY BACTERIAL PATHOGENS, 2018-2032 (USD MILLION)
TABLE 263. AFRICA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 264. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 265. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 266. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 267. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2032 (USD MILLION)
TABLE 268. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2032 (USD MILLION)
TABLE 269. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 270. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 271. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY INFECTION SITE, 2018-2032 (USD MILLION)
TABLE 272. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY LOWER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 273. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY UPPER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 274. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 275. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 276. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY BACTERIAL PATHOGENS, 2018-2032 (USD MILLION)
TABLE 277. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 278. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 279. ASEAN URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 280. ASEAN URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 281. ASEAN URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 282. ASEAN URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2032 (USD MILLION)
TABLE 283. ASEAN URINARY TRACT INFECTION MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2032 (USD MILLION)
TABLE 284. ASEAN URINARY TRACT INFECTION MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 285. ASEAN URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 286. ASEAN URINARY TRACT INFECTION MARKET SIZE, BY INFECTION SITE, 2018-2032 (USD MILLION)
TABLE 287. ASEAN URINARY TRACT INFECTION MARKET SIZE, BY LOWER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 288. ASEAN URINARY TRACT INFECTION MARKET SIZE, BY UPPER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 289. ASEAN URINARY TRACT INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 290. ASEAN URINARY TRACT INFECTION MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 291. ASEAN URINARY TRACT INFECTION MARKET SIZE, BY BACTERIAL PATHOGENS, 2018-2032 (USD MILLION)
TABLE 292. ASEAN URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 293. GCC URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 294. GCC URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 295. GCC URINARY TRACT INFECTION MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 296. GCC URINARY TRACT INFECTION MARKET SIZE, BY NON ANTIBIOTIC THERAPIES, 2018-2032 (USD MILLION)
TABLE 297. GCC URINARY TRACT INFECTION MARKET SIZE, BY DIAGNOSIS METHOD, 2018-2032 (USD MILLION)
TABLE 298. GCC URINARY TRACT INFECTION MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 299. GCC URINARY TRACT INFECTION MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 300. GCC URINARY TRACT INFECTION MARKET SIZE, BY INFECTION SITE, 2018-2032 (USD MILLION)
TABLE 301. GCC URINARY TRACT INFECTION MARKET SIZE, BY LOWER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 302. GCC URINARY TRACT INFECTION MARKET SIZE, BY UPPER TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 303. GCC URINARY TRACT INFECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 304. GCC URINARY TRACT INFECTION MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 305. GCC URINARY TRACT INFECTION MARKET SIZE, BY BACTERIAL PATHOGENS, 2018-2032 (USD MILLION)
TABLE

Companies Mentioned

The key companies profiled in this Urinary Tract Infection market report include:
  • AbbVie Inc.
  • Almirall, SA
  • Aspen Pharmacare Holdings Limited
  • AstraZeneca PLC
  • Bayer AG
  • Beckman Coulter, Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Cipla Limited
  • Dr Reddys Laboratories Ltd.
  • Eli Lilly and Company
  • F Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Lupin Ltd.
  • Merck & Co Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • PhenUtest Diagnostics Ltd.
  • Randox Laboratories Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Shionogi & Co, Ltd.
  • Siemens Healthineers AG
  • Sun Pharmaceutical Industries Limited
  • Sysmex Corporation
  • Teva Pharmaceutical Industries Ltd.
  • URIT Medical Electronic Co., Ltd.
  • Viatris Inc

Table Information

Report AttributeDetails
No. of Pages188
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 10.96 Billion
Forecasted Market Value ( USD ) by 2032 $ 16.62 Billion
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Urinary Tract Infection (UTI) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, Form, Source, End Use, Sales Channel, Geographic Coverage and By Company) - Product Image

Urinary Tract Infection (UTI) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, Form, Source, End Use, Sales Channel, Geographic Coverage and By Company)

  • Report
  • 210 Pages
  • Global
From
Urinary Tract Infection Treatment Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Urinary Tract Infection Treatment Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 88 Pages
  • Global
From
Urinary Tract Infection Treatment Market Report 2025 - Product Image

Urinary Tract Infection Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Uncomplicated Urinary Tract Infection Epidemiology Forecast 2025-2034 - Product Image

Uncomplicated Urinary Tract Infection Epidemiology Forecast 2025-2034

  • Report
  • 150 Pages
  • Global
From
Uncomplicated Urinary Tract Infection Treatment Market Report 2025 - Product Image

Uncomplicated Urinary Tract Infection Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Urinary Tract Infection Drug Market

The Urinary Tract Infection Drug market is a subset of the Urological Disorders Drugs market. It is composed of drugs used to treat urinary tract infections (UTIs), which are caused by bacteria entering the urinary tract. These drugs are typically antibiotics, such as sulfonamides, cephalosporins, and fluoroquinolones. They are used to kill the bacteria and reduce the symptoms of the infection. Other drugs, such as antifungals, may also be used to treat UTIs. The Urinary Tract Infection Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, Sanofi, and Novartis. These companies are constantly developing new drugs to treat UTIs, as well as other urological disorders. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.